Bizarre Patents
A method for inducing cats to exercise consists of directing a beam of invisible light produced by a hand-held laser apparatus onto the floor or wall.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7674827 | Indanyl- and tetrahydronaphtyl-amino-thiourea compounds for combating animal pests Indanyl- and Tetrahydronaphtyl-amino-thiourea compounds for combating animal pests The present invention relates to Indanyl- and Tetrahydronaphtyl-amino-thiourea compounds of formula I wherein the variables R1 | 03/09/2010 |
| 7285574 | Methods for treating neural cell swelling A composition comprising a novel Ca2+-activated, [ATP]i-sensitive nonspecific cation (NCCa-ATP) channel is described. The channel is found in mammalian neural cells and exhibits a different sensitivity to block by various adenine nuc... | 10/23/2007 |
| 6875793 | Once-a-day controlled release sulfonylurea formulation This invention is directed to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of a sulfonylurea or a salt or derivative thereof in the matrix. Further, the use of an aqueous alkalizing med... | 04/05/2005 |
| 6852760 | Compositions and methods for treatment for glucose metabolism disorders Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium. ... | 02/08/2005 |
| 6822001 | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel. ... | 11/23/2004 |
| 6693094 | Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus The invention describes formulations that include either metformin, sulfonylurea or a biguanide-sulfonylurea combination as one active ingredient in addition to specific, other active ingredients. The compositions and dosage forms of the invention are cli... | 02/17/2004 |
| 6576632 | Biaryl compounds useful as anticancer agents The present invention relates to compounds of formula I ##STR1## and to pharmaceutically acceptable salts, hydrates and prodrugs thereof, wherein R1, R2, R3, R4, R5, R10, R11, b,... | 06/10/2003 |
| 6555519 | O-glucosylated benzamide SGLT2 inhibitors and method SGLT2 inhibiting compounds are provided having the formula ##STR1## wherein n is 0, 1 or 2; A is ##STR2## or heteroaryl which may contain 1 to 4 heteroatoms in the ring which may be selected from N, O, S, SO, and/or SO2, bearing substituents ... | 04/29/2003 |
| 6511989 | Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them One embodiment of the present invention relates to acylaminoalkyl-substituted benzenesulfonamide derivatives of the formula (I), ##STR1## in which A, R(1), R(2), X, Y, and Z have the meanings indicated in the specification, and to pharmaceutically to... | 01/28/2003 |
| 6500863 | Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists Novell IL-8 compounds and methods of using them are provided.... | 12/31/2002 |
| 6414030 | Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers Substituted benzenesulfonylureas and -thioureas of the formula I ##STR1## in which R1, R2, E, X, Y and Z have the meanings described herein, show effects on the autonomous nervous system. The invention relates to the use of the compo... | 07/02/2002 |
| 6350778 | Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use, and pharmaceutical preparations comprising them The present invention relates to cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives of formula I ##STR1## in which A(1), A(2), A(3), R(1), R(2), R(3), R(4), X, Y, and Z have the meanings indicated in the claims. Compounds of formula I are valu... | 02/26/2002 |
| 6140368 | Naphthols useful in antiviral methods The present invention relates to a novel class of compounds that are potent inhibitors of HIV reverse transcriptase and HIV integrase. In addition to being multienzyme inhibitors, the inventive compounds of the present invention are remarkable in at least... | 10/31/2000 |
| 6103761 | Agents acting at cholecystokinin receptors The invention concerns a series of novel bis-urea derivatives, nonpeptides, which show good binding affinity for the CCK-B receptor. The compounds, compositions containing them, methods of preparation, and utilities including anxiety, gastric acid secreti... | 08/15/2000 |
| 6071910 | Use of agents to treat eosinophil-associated pathologies A therapeutic method comprising counteracting or preventing pathologies mediated by IL-5, including those characterized by eosinophil infiltration, degranulation and inflammation, by administering to a mammal in need of such therapy, one or more compounds... | 06/06/2000 |
| 6011049 | Combinations for diabetes Combinations of a glitazone antidiabetic agent and a biguanide antidiabetic agent, and optionally a sulfonylurea antidiabetic agent, are useful for treating diabetes mellitus and improving glycemic control.... | 01/04/2000 |
| 5981595 | Sulfonyl urea and carbamate ACAT inhibitors A pharmaceutically useful compound which lowers blood cholesterol levels having the formula ##STR1## wherein X is oxygen or --NH--; Ar is phenyl, substituted phenyl, naphthyl or substituted naphthyl; R1 is hydrogen, lower alkyl or benzyl; ... | 11/09/1999 |
| 5977177 | Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them This invention relates to substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them. Substituted benzenesulfonylureas and -thioureas of the ... | 11/02/1999 |
| 5972973 | Sulfonylurea-glitazone combinations for diabetes Combinations of a sulfonylurea antidiabetic agent and a glitazone antidiabetic agent are useful for treating diabetes mellitus and improving glycemic control.... | 10/26/1999 |
| 5885980 | Composition and method for treating diabetes A method of treating diabetes in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of a pharmaceutically acceptable VO+2 generating compound and a therapeutically effective amount of microniz... | 03/23/1999 |
| 5880155 | Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them This invention relates to substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them. Substituted benzenesulfonylureas and -thioureas of the ... | 03/09/1999 |
| 5859037 | Sulfonylurea-glitazone combinations for diabetes Combinations of a sulfonylurea antidiabetic agent and a glitazone antidiabetic agent are useful for treating diabetes mellitus and improving glycemic control.... | 01/12/1999 |
| 5856360 | Pharmaceutical method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock This invention is directed to a pharmacologically acceptable composition for inhibiting or treating hemorrhagic shock in a mammal. The composition includes a KATP inhibitor and a pharmacologically acceptable carrier, with the KATP in... | 01/05/1999 |
| 5776980 | Substituted benzenesulfonylureas and -thioureas-process for their preparation and their use as pharmaceuticals Benzenesulfonylureas and -thioureas of the formula I ##STR1## where R(1) is H or (fluoro)methyl, R(2) is H, Hal or (fluoro)(mercapto)alk(oxy)yl, E is O or S; Y is --CR(3)2 !n --, where R(3)=H or alkyl and n=1-4, X is H, Hal or... | 07/07/1998 |
| 5698596 | Substituted benzenesulfonylureas and thioureas process for their preparation and their use as pharmaceuticals Substituted benzenesulfonylureas and -thioureas--processes for their preparation and their use as pharmaceuticals Benzenesulfonylureas and -thioureas of the formula I ##STR1## where R(1) is H or (fluoro)methyl, R(2) is H, Hal or (fluoro)(mercapto)alk... | 12/16/1997 |
| 5677344 | Method for treating Parkinson's disease employing an ATP-sensitive potassium channel blocker A method is provided for treatment of Parkinson's disease or controlling movement of a Parkinsonian patient by administering an ATP-sensitive potassium channel blocker, such as a sulfonyl urea, (for example, tolbutamide), or quinine.... | 10/14/1997 |
| 5652268 | Substituted benzenesulfonylureas and-thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them This invention relates to substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them. Substituted benzenesulfonylureas and -thioureas 1 ##STR1## exhibit ef... | 07/29/1997 |
| 5633239 | Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them Substituted benzenesulfonylureas and -thioureas of the formula I ##STR1## exhibit outstanding effects on the cardiovascular system.... | 05/27/1997 |
| 5607976 | Substituted benzenesulfonyl-thioureas and pharmaceutical preparations containing them Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them. Substituted benzenesulfonylureas and -thioureas of the formula I ... | 03/04/1997 |
| 5574069 | Substituted benzenesulfonylureas and -thioureas- process for their preparation and their use as pharmaceuticals Benzenesulfonylureas and -thioureas of the formula I ##STR1## where R(1) is H or (fluoro)methyl, R(2) is H, Hal or (fluoro) (mercapto) alk (oxy) yl, E is O or S; Y is --[CR(3)2 ]n-, where R(3)=H or alkyl and n=1-4, X is H, Hal or alkyl and... | 11/12/1996 |
| 5565494 | Antitumor compositions and methods of treatment This invention provides certain benzenesulfonamide derivatives and methods for using them in the treatment of susceptible neoplasms in mammals. Also provided are certain novel pharmaceutical formulations employing these benzenesulfonamide derivatives in c... | 10/15/1996 |
| 5451580 | Method for treating insult to neurons prone to Parkinson's degeneration employing an ATP-sensitive potassium channel blocker A method is provided for treatment of neuronal insult, such as caused by lack of oxygen, which neurons are prone to Parkinsonian degeneration by administering an ATP-sensitive potassium channel blocker, such as a sulfonyl urea, for example, tolbutamide.... | 09/19/1995 |
| 5389682 | Agents acting at cholecystokinin receptors The invention concerns a series of novel bis-urea derivatives, nonpeptides, which show good binding affinity for the CCK-B receptor. The compounds, compositions containing them, methods of preparation, and utilities including anxiety, gastric acid secreti... | 02/14/1995 |
| 5288757 | Aminosulfonyl urea ACAT inhibitors and a method of lowering blood cholesterol levels therewith The present invention provides pharmaceutically useful compounds which are aminosulfonyl urea compounds which are ACAT inhibitors rendering them useful in controlling blood cholesterol levels, pharmaceutical compositions and methods of using the ACAT inhi... | 02/22/1994 |
| 5258406 | Sulfonimidamides This invention provides certain sulfonimidamide compounds, formulations and method of use of these compounds in treating susceptible neoplasms.... | 11/02/1993 |
| 5234955 | Antitumor compositions and methods of treatment This invention provides certain N-phenyl-N'-substitutedphenylsulfonylureas compounds, formulations, and a method for treating susceptible neoplasms in mammals using the sulfonylurea compounds.... | 08/10/1993 |
| 5234922 | Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea Methods for the treatment of secretory diarrhea comprised of administering to a patient in need thereof, an effective amount of a CFTR chloride channel blocker or a potassium channel opener are disclosed. The CFTR chloride channel blocker is a sulfonylure... | 08/10/1993 |
| 5215985 | Method for treating ischemic insult to neurons employing an ATP-sensitive potassium channel blocker A method is provided for treatment of neuronal insult, such as caused by lack of oxygen, by administering an ATP-sensitive potassium channel blocker, such as a sulfonyl urea, for example, tolbutamide.... | 06/01/1993 |
| 5116861 | Nitrosothiol derivatives and their use Novel nitrosothiol derivatives of the formula: ##STR1## wherein R1 and R2 are independently a hydrogen atom or a hydrocarbon residue which may be substituted; R3 is a hydrogen atom, an acyl group or a hydrocarbon resi... | 05/26/1992 |
| 5047429 | Treatment of oedema A method is described for treating and/or preventing pulmonary oedema in patients comprising administering a suphonylurea compound or a pharmaceutically acceptable salt thereof to patients who suffer from or are susceptible to oedema. Glucose may also be ... | 09/10/1991 |
